SEC Form D · filed October 28, 2021
Vyripharm Enterprises, Inc
Offering
$300.0M
Sold
$300.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HOUSTON, TX
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (2)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗